despite these advancements, these traditional models have failed to deliver any therapies approved to target these interactions. For example, despite many neurotoxic chemotherapeutics being on the market for decades, there are no treatments available that prevent or ameliorate their effects on the nervous system. Similarly, there are no therapies approved that leverage cancer-PNS interactions as an antineoplastic mechanism. These clinical failings are largely due to the technical and translational limitations of the experimental models routinely used for studying PNS disorders. To make research in the evolving area of cancer neuroscience more translational and compatible with drug discovery an interdisciplinary approach utilizing tools that span cancer biology, developmental biology, functional genomics, neuroscience, and pharmacology must be employed. Here, human stem cell-derived cultures are discussed as exciting model systems that may help incorporate novel methodologies into cancer and cancer therapy PNS research.